About 4 200 reports

Chemical and Pharmaceutical Plants Construction in Spain to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Spain to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

400 500 320
Jun 2015

Chemical and Pharmaceutical Plants Construction in South Korea to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in South Korea to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Jun 2015

Chemical and Pharmaceutical Plants Construction in Australia to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Australia to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Jun 2015

Chemical and Pharmaceutical Plants Construction in Myanmar to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Myanmar to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Jun 2015

Chemical and Pharmaceutical Plants Construction in Indonesia to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Indonesia to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Jun 2015

Chemical and Pharmaceutical Plants Construction in Peru to 2019: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Peru to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

400 500 320
Jun 2015

Indonesia Pharmaceuticals and Healthcare Report Q3 2015

150 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Indonesia's healthcare expenditure will grow robustly. Key to this trajectory is rising household incomes which will have strong positive ramifications due to the dominant role of private spending as a source of healthcare financing. This will be further augmented by the...

985 1 300 818
Jun 2015

Qatar Pharmaceuticals and Healthcare Report Q3 2015

105 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Qatar's Annual Health Report for 2014 confirms our view that the healthcare sector will experience strong growth over our forecast period. Sizeable expansion projects are underway, health insurance coverage is increasing and government spending will remain elevated given...

985 1 300 818
Jun 2015

Spain Pharmaceuticals and Healthcare Report Q3 2015

102 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Spain's non-transparent and unpredictable government medicine pricing system and theimplementation of numerous emergency measures to contain pharmaceutical spending will highly disrupt multinational drugmakers' strategy and revenue streams. Despite the Spanish economy...

985 1 300 818
Jun 2015

Namibia Pharmaceuticals and Healthcare Report Q3 2015

55 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pharmaceuticals originating from neighbouring South Africa dominate the domestic market, with Indian firms also having a strong presence. The market is mostly comprised of generic medicines, though patented drugmakers do supply the Namibian pharmaceutical market as well....

985 1 300 818
Jun 2015

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2015

84 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Domestic generic drugmakers will be at a distinct advantage under Sri Lanka's proposed national medicinal policy. With directives boosting generic drug sales through generic substitution, local pharmaceutical companies will be further assisted as the government aims to use...

985 1 300 818
Jun 2015

Serbia Pharmaceuticals and Healthcare Report Q3 2015

106 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: A focus on reining in Serbia's bloated public sector following an agreement with the IMF will inevitably lead to cuts in healthcare spending. Furthermore, Serbia's healthcare authorities will continue to cut prices to reduce their pharmaceutical expenditure as a means to...

985 1 300 818
Jun 2015

Belgium Pharmaceuticals and Healthcare Report Q3 2015

108 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With structurally higher prices than many regional markets and quickly rising pharmaceutical onsumption, Belgium will continue to present a high level of potential reward to drugmaker. Notably, a distinct lack of price transparency within the pharmaceutical value chain will...

985 1 300 818
Jun 2015

Wound Care in South Korea

20 pages • By Euromonitor International

Wound care recorded 8% value growth in 2014 due to gradual growth of sticking plasters/adhesive bandages and strong increase of gauze, tape and other wound care at 11%. Gauze, tape and other wound care continued to see healthy growth thanks to hydrate tape. As hydrate tape helps skin to heal without ointment, it became a new trend in South...

800 1 064 712
Jun 2015

Consumer Health in South Korea

98 pages • By Euromonitor International

Consumer health had strong growth in 2014 although it was lower than in the review period. OTC products increased due to the good performance of the existing and newly introduced products and active marketing activities by the major players. Vitamins and dietary supplements saw lower growth than in the review period but it maintained positive...

2 125 2 826 1 891
Jun 2015

Digestive Remedies in South Korea

22 pages • By Euromonitor International

Digestive remedies sales increased by 1% in 2014 due to growth of antacids and digestive enzymes, although there was weak performance of paediatric digestive remedies which had value decline of -2%. Paediatric diarrhoeal remedies also had a weak performance with -3% value growth. Laxatives also had a negative performance with -4% value decline...

800 1 064 712
Jun 2015

Sports Nutrition in South Korea

20 pages • By Euromonitor International

Sports nutrition saw 6% current value growth in 2014. The trend for a fit body with muscle definition was prevalent for years with male celebrities in South Korea. Many male consumers tried to train their bodies and more women began to make their bodies look healthier and fitter. As there was more attention to improve body shape, personal...

800 1 064 712
Jun 2015

Adult Mouth Care in South Korea

19 pages • By Euromonitor International

Adult mouth care recorded 7% value growth in 2014 as the number of stomatitis patients increased due to stress. Leading manufacturers also actively developed new strategies for their products and increased value sales. For example, companies focused on themes of self-medication in 2014 and advertised their OTC products to consumers as their...

800 1 064 712
Jun 2015

Dermatologicals in South Korea

22 pages • By Euromonitor International

Dermatologicals had value growth of 2% in 2014 due to the growth of major brands in topical germicidals/antiseptics. Topical germicidals/antiseptics saw 9% value growth in 2014 due to the aggressive marketing activities and the good performance in grocery retailers such as hypermarkets and convenience stores. Topical germicidals/antiseptics...

800 1 064 712
Jun 2015

Iran Pharmaceuticals and Healthcare Report Q3 2015

120 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The gradual easing of sanctions in Iran will lead to an uptick in interest from multinational pharmaceutical companies, many of which chose not to do business in Iran during this time. The supply ofhigh value patented medicines will still be satisfied by multinationals despite increasing...

985 1 300 818
Jun 2015

Italy Pharmaceuticals and Healthcare Report Q3 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Drugmakers will continue to face revenue earning challenges in Italy. In 2014, spending by Italy's national healthcare service, Servizio Sanitario Nazionale (SSN), fell for the seventh consecutive year in which SSN spending on drugs declined. SSN pharmaceutical expenditure will decline...

985 1 300 818
Jun 2015

China Pharmaceuticals and Healthcare Report Q3 2015

200 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Multinational pharmaceutical companies will continue to invest and grow their presence in China, despite the slowdown in the economy. Driving this outlook is the outperformance of the pharmaceutical sector as authorities continue to improve healthcare access through stronger medical...

985 1 300 818
Jun 2015

Cuba Pharmaceuticals and Healthcare Report Q3 2015

76 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: A new focus on the improvement of global trade ties along with economic liberalisation, albeit slow, will ensure Cuba's healthcare and pharmaceutical markets continue their positive growth trajectory over the long-term. Initial steps toward US cooperation with the island's pharmaceutical...

985 1 300 818
Jun 2015

Bangladesh Pharmaceuticals and Healthcare Report Q3 2015

99 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Bangladesh's pharmaceutical and healthcare sector growth will continue to stand on robust long-term fundamentals, including population growth, rising incomes, urbanisation and economic expansion. Moreover, the country's efforts to increase drug manufacturing capacity both for domestic...

985 1 300 818
Jun 2015

Moldova Pharmaceuticals and Healthcare Report Q3 2015

86 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Moldova is heavily dependent on the success of outside sources, such as the European and Russian economy. In this regard, Moldova's economy is continuing to suffer greatly from the declining euro vs the US dollar and GBP combined with the full force of Western sanctions against the...

985 1 300 818
Jun 2015

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2015

83 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Our outlook of modest growth for Zimbabwe's pharmaceutical sector should be treated with caution as poor monitoring and recording practices along with the country's reliance on aid from various sources make market figures unreliable. Pharmaceutical spending will be driven mainly by...

985 1 300 818
Jun 2015

Ireland Pharmaceuticals and Healthcare Report Q3 2015

88 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: In line with our long-standing view, merger and acquisition activity targeting Irishpharmaceutical firms has remained intense in H115, while this trend is expected to continue over a multiquarter horizon against a backdrop of strong fundamentals and Ireland's government policies to...

985 1 300 818
Jun 2015

Slovakia Pharmaceuticals and Healthcare Report Q3 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Eurozone recovery and an improving domestic economic outlook will provide a boost to healthcare expenditure in Slovakia in the short-term. Over the longer term, we expect healthcare spending to accelerate given Slovakia's ageing population and burden of chronic diseases. With public...

985 1 300 818
Jun 2015

Morocco Pharmaceuticals and Healthcare Report Q3 2015

114 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Similar to other North African markets, Morocco's inclusion on PhRMA's Special 301 Submission for 2015 for intellectual property and pricing issues highlights the ongoing challenges thatmultinational drugmakers face in the market. However, we expect innovative drugmakers to continue...

985 1 300 818
Jun 2015

Philippines Pharmaceuticals and Healthcare Report Q3 2015

132 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Innovative pharmaceutical companies will continue to face a challenging business environment in the Philippines. Many concerns limiting the sales of patented drugs in the country remain unaddressed, including the low levels of intellectual property protection. Furthermore, pricing pressures...

985 1 300 818
Jun 2015